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INTRODUCTION: Amyloidosis in elderly individuals can be an independent alteration and a characteristic of aging. However,
the clinical, pathophysiologic, and biochemical characteristics of amyloidosis related to age remain uncertain.
OBJECTIVE: The purpose of this study was to determine the extent to which the heart and/or the brain of individuals aged 60
years or over exhibits amyloid deposits.
MATERIALS AND METHODS: The autopsy findings of individuals who were at least 60 years old were studied. The autopsies
took place between the years of 1976 and 2000. A total of 10 cases were selected that had hearts without cardiopathies, had
negative serology for Chagas’ disease, and had brains without morphological changes related to encephalopathies. Slides with
fragments of heart and brain were processed and analyzed using polarized and common light microscopy.
RESULTS: Of the 10 cases, 4 were positive for amyloidosis. All had positive findings in the brain, and 1 case also had positive
findings in the heart. Among the positive cases, 50% were of people aged 60 to 69 years. There appeared to be a relationship
between the presence of amyloid deposits and the ratio of brain and body weight, with the ratio in the positive cases being smaller
than in the negative cases.
CONCLUSIONS: The analysis of amyloid deposits in the brains and hearts of elderly individuals shows that such deposits may
lead to a systemic attack of senility, common to natural aging. It is not certain that beta-amyloid deposits would alone bring such
drastic repercussions to the individual. Some additional disorders of the organism could cause the breakdown of the natural
balance related to the accumulation of these proteins, leading the way to the pathological contexts of amyloidosis.
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INTRODUCTION
The elderly population has increased over time.¹ With
aging, several alterations, including amyloidosis (beta-
fibrilosis)² may occur. Amyloidosis, a common structural
arrangement, may present different chemical characteris-
tics.³ The most frequent are those from light chains of
immunoglobulins found in the alteration of plasma cells,
and from AA substance in the serum that are associated
with the inflammatory process. Cardiac amyloidosis in eld-
erly individuals can occur regardless of other diseases and
is typical of aging, with the heart being the most frequently
affected organ.4 In these cases, amyloidosis may be asso-
ciated with cardiovascular lesions, such as electrocardio-
graphic anomalies,5 congestive heart, and atrial fibrilla-
tion.6
In recent years, interest in amyloidosis associated with
aging has increased, largely due to Alzheimer’s disease, a
chronic degenerative disease with a high incidence in our
population.7 Alzheimer’s disease presents extracellular de-
posits of beta-fibrils.8 With aging, the brain loses the ca-
pacity to eliminate these naturally formed proteins, lead-
ing to deposits.9 Areas such as the hippocampus and amy-
gdala that constitute the limbic system are common loca-
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tions for the deposits of these beta-fibril plaques.10,11 Amy-
loidosis may thus be conceived as the morphological ex-
pression of Alzheimer’s disease.12 Nevertheless, controver-
sies exist.8,13 Some authors believe that amyloidosis in
Alzheimer’s disease is not formally associated with aging.14
The only systemic form of amyloidosis formally associated
with aging is senile systemic amyloidosis, also called se-
nile cardiac amyloidosis, due to the prevalence of these de-
posits in the hearts of elderly individuals, described in 25%
of the cases of individuals above the age of 80 14 and in
65% of the patients above 90 years of age, but not frequent
in individuals under 60 years of age.6
The influence of the aging process as a factor that con-
tributes to the deposits of these proteins is well known.
However, the clinical, the pathophysiologic, and the bio-
chemical characteristics of amyloidosis associated with ag-
ing remain uncertain. Therefore, the aim of this study was
to determine the extent to which the hearts and brains of
individuals over the age of 60 contain amyloid material.
MATERIAL AND METHODS
Consecutive autopsy reports of elderly individuals over
the age of 60 were studied. The autopsies were performed
at the Triângulo Mineiro Federal University Medical School
Hospital in the city of Uberaba during the period of 1976
to 2000, by the General Pathology Service. Samples and
slides of hearts and brains corresponding to the selected
reports were located. A spreadsheet was prepared to include
the following variables: the number of the report and the
year of the autopsy, age, gender, ethnicity, origin, cause of
death, body weight, height, body mass index (BMI), weight
of the heart, weight of the brain, ratio of the weights of
the heart and body, and ratio of the weights of the brain
and body. These data were obtained from the autopsy re-
ports.
Amyloidosis was studied in hearts without cardiopa-
thies. Ischemic, hypertensive, chagasic, and valvar cardio-
pathies, as determined by anatomic/pathological examina-
tions, were excluded. Furthermore, hearts from individu-
als who tested positive for Chagas disease were excluded.
Cases with brains having morphological alterations related
to encephalopathies were also excluded. Of a total of 576
cases, 10 cases autopsied during the 1980s and 1990s were
selected for the study.
In order to quantify the amyloid deposits, for each au-
topsy, two 8-micrometer slides of serial cuts of fragments
of the aorta, pulmonary trunk, atria, ventricles of the heart,
and right and left hippocampus were processed. One of the
slides was stained with hematoxylin-eosin for general mor-
phological analysis, while the other was stained with Congo
red to identify amyloidosis. For the confirmation of the
amyloid deposits, analysis of the slides was done both un-
der common and polarized light microscope.
The nutritional status of the individuals was considered
using the BMI.2. For values below 22 or above 27 kg/m2,
the individuals were considered undernourished or over-
weight, respectively.15
Statistical analysis was performed using the
Kolmogorov-Smirnof test. Comparison between 2 groups
with normal distribution was verified by the Student t test,
and the association between qualitative variables was veri-
fied using Fischer’s Exact test. The level of significance
was established at P < 0.05 (5%).
RESULTS
The average age of the elderly individuals was 73.6 ±
10.5 years, with a predominance of Caucasian individuals
(60%) between 60 and 79 years of age (80%), of the fe-
male gender (60%). As for the geographic origins, the in-
dividuals were predominantly from the city of Uberaba
(80%). The most frequent cause of death was infection
(60%) (Table 1). The average BMI was 20.5 ± 3.8 kg/m2
(mean ± std dev), with a majority of the individuals con-
Table 1 - Distribution of the demographic data of the 10
individuals
Demographic dada Positive Negative  Total (%)
(n = 10) Amyloidosis Amyloidosis
Autopsy (decade)
1981 to 1990 1 2 03 30
1991 to 2000 3 4 07 70
Age (years)
60 to 69 2 2 04 40
70 to 79 1 3 04 40
≥ 80 1 1 02 20
Gender
Male 1 3 04 40
Female 3 3 06 60
Ethnicity
Caucasian 2 4 06 60
Noncaucasian 2 2 04 40
Origin
Uberaba 4 4 08 80
Not Uberaba 0 2 02 20
Nutritional status
Normal Nutrition 1 3 04 60
Undernonrished 3 3 06 60
Cause of death
Infection (I) 3 3 06 60
Neoplasia 0 3 03 30
Heart Disease 1 0 01 10
Fischer’s Exact Test: Amyloidosis X: decades (81-90); (91-00), P = 0.467;
Age (60-79, >=80), P = 1.000; Nutritional status (NN; UN), P = 0.571;
gender (M; F), P = 0.571; ethnicity (C; NC), P = 1.000; origin (U; NU), P
= 0.467; cause of death (I; NI*), P = 0.464; *(NI): noninfectious
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sidered undernourished (60%). The average weight of the
brain was 1307 ± 180.1 g, and the ratio of weight of the
brain and the body was 0.60 ± 0.63%. Amyloidosis was
observed in 4 brains (40%), with 2 of the cases being of
beta-fibril deposits found in the hippocampus of both hemi-
spheres (Figure 1). The deposits were characterized by a
focal and discrete distribution, appearing as dark orange-
colored amorphous deposits under common light and ap-
ple-green birefringent under polarized light. Additionally,
the amyloid deposit was located next to the cell body of
neurons, and in 1 field, the deposit was seen on the wall
of a blood vessel. The average age of individuals with amy-
loid (75.0 ± 10.8 years) was greater than that of individu-
als without amyloid deposits (72.7 ± 11.1 years); however,
this difference was not statistically significant (t = 0.356;
P = 0.753). In the positive cases, the ratio of the weight of
the brain and body was significantly smaller than in the
negative cases (t = 2.683; P = 0.028). There was no sig-
nificant difference between the average BMI in the posi-
tive compared to the negative cases (Table 2).
The amyloid process was identified in only 1 heart
(10%). The weight of this heart was 280 g, and the ratio
of the weight of the heart and the body was 0.55%. Simi-
larly to the findings in the brain, the deposits were charac-
terized by a focal and discrete distribution. The amyloid
deposit was found among the cardiac myocytes of the left
atrium. In this particular case, deposits of amyloid protein
were also present in the individual’s brain.
DISCUSSION
The present study characterized amyloidosis in the hip-
pocampus of both hemispheres of autopsied elderly indi-
viduals. The positive cases in this study represent 40% of
the cohort. For centenary individuals, deposits of amyloido-
sis have been reported in over 90% of the cases.16 Accord-
ingly, the hypothesis that individuals with ages above 60
present deposits of amyloid material is supported by our
findings.
In the present study, deposits of beta fibrils did not sig-
nificantly increase with age, which differs from reports in
the literature.17 However, the discrepancy may be due to
the small size of the sample in this study.
The ratio of the weight of the brain and body showed
a significant association with the positive cases, with a
smaller ratio in the positive cases. No similar data was
found in the literature. A possible explanation for the
smaller value in the brain weight/body weight ratio of the
positive cases could be in the systemic edema presented
by all positive cases, which could be overvaluing the body
weight. Nevertheless, when this hypothesis was tested, no
statistically significant difference was found. On the other
hand, a possible cerebral atrophy of these patients could
be a contributing factor for this finding.
Amyloidosis is considered by some authors to be an ac-
tivity index for the process of Alzheimer’s disease. This is
because the beta-fibril deposits represent a sum of several
processes that generate neuronal lesions, and their presence
is an indication of the activity of the disease.12
Table 2 - Relationship of the demographic data and the
amyloidosis of the 10 individuals
Amyloidosis (Mean ± std dev)
Positive Negative
Age (years) 75.0 ± 10.8 72.66 ± 11.12
Brain weight (g)* 1435 ± 146.17 1208.33 ± 127.97
Brain weight/Body weight (%)* 0.58 ± 0.10 0.62 ± 0.61
Body Mass Index (kg/m²) 19.3 ± 3.62 21.32 ± 4.02
Age: t = -0.326; P = 0.753; Brain weight: t = 2.829, P = 0.022; Brain weight/
Body weight: t = 2.683, P = 0.028; Body Mass Index: t = 0.806,
P = 0.444
Figure 1 - Histological section from the hippocampus of an autopsied patient.
Note the deposit of congophilic material, in orange, seen under common
light, birefringent in apple-green under polarized light, characterizing
amyloidosis (Congo-red stain, 40x, under common light – A and under
polarized light – B)
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The natural history of Alzheimer’s disease seems to be
more dramatic when it affects younger individuals.18 On the
other hand, the accuracy of the Alzheimer’s disease diag-
nosis is lower than 80% to 90%, especially in the early
stages of the disease.19 The average life span of patients
with diagnosis made between the age of 60 and early 70s
varies from 7 to 10 years, dropping to less than 3 years
when diagnosis occurs after the age of 90.20 This fact dem-
onstrates a relationship between age of the diagnosis and
a prognosis for the patient.21 Early detection of Alzheim-
er’s disease might result in a better prognosis for these pa-
tients, emphasizing the importance of studies that contrib-
ute to a better understanding of the disease. In the present
study, 40% of the cases were positive for amyloidosis. Of
these cases, 50% were in the 60 to 69 age range. As de-
scribed above, this age range constitutes the most critical
and important period for performing the diagnosis. The
more complete the findings of the natural history of this
disease, the greater are the chances for the developing of
an early intervention aimed at impeding the progress of this
class of disease. Furthermore, the development of
antiamyloid medication may be essential in elucidating the
pathophysiology of Alzheimer’s disease.8
In this study, an 89-year-old individual presented focal
amyloidosis in the left atrium corresponding to 10%, an
index lower that those described in the literature.22,23 The
focal distribution of amyloidosis was similar to that de-
scribed in literature characterizing the senile cardiac amy-
loidosis. No statistically significant relationship was found
in this study between the positive cases and gender, age,
ethnical origin, BMI, weight of the heart, and ratio of the
weights of the heart and body. Senile cardiac amyloidosis
may increase the weight of hearts.14
In conclusion, the findings of amyloidosis in the brains
and hearts of elderly individuals without morphological al-
terations compatible with pathological entities in these or-
gans may guide us towards treating systemic occurrences
of amyloidosis in elderly individuals. Amyloid deposits are
a result of a common process in the natural aging of hu-
man beings. Some organic disorder might cause the loss
of the natural balance for the deposits of these proteins,
leading to the pathological context of amyloidosis.
RESUMO
Nunes LM de E, Salge AKM, de Oliveira FA, Teixeira V
de PA, dos Reis MA. Beta-fibrilose encefálica e cardíaca
em idosos autopsiados. Clinics. 2006;61(2): 113-8.
INTRODUÇÃO: A amiloidose em idosos pode ser uma
alteração independente e própria do envelhecimento.
Entretanto, as características clínicas, fisiopatológicas e
bioquímicas da Amiloidose relacionada à idade ainda
permanecem incertas.
OBJETIVO: Verificar se o coração e o encéfalo de
indivíduos acima de 60 anos apresentavam depósito
amilóide.
MATERIAL E MÉTODOS: Foram estudados laudos
consecutivos de autópsias de indivíduos acima de 60 anos
realizadas entre 1976 e 2000, que apresentavam corações
sem cardiopatias, com sorologia negativa para Doença de
Chagas e encéfalos sem alterações morfológicas de
encefalopatias, chegando a um n de 10 casos. Lâminas de
fragmentos do coração e de encéfalo foram processadas e
analisadas em microscopia de luz comum e polarizada.
RESULTADOS: Dos 10 casos, 3 apresentaram depósito
amilóide no encéfalo e 1 no encéfalo e no coração. Em 50%
dos casos, os indivíduos tinham entre 60 e 69 anos. A
relação entre o peso encefálico e o peso corporal mostrou
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